ML 18
- Product Name
- ML 18
- CAS No.
- 1422269-30-4
- Chemical Name
- ML 18
- Synonyms
- ML 18;ML18, >98%;BRS-3 antagonist;ML18;ML-18;ML 18;BRS-3 ANTAGONIST;1422269-30-4;Bombesin Receptor,ML-18,ML 18,inhibit,Inhibitor,ML18;(S)-3-(1H-Indol-3-yl)-N-((1-(4-methoxyphenyl)cyclohexyl)methyl)-2-(3-(4-nitrophenyl)ureido)propanamide;(2S)-3-(1H-INDOL-3-YL)-N-{[1-(4-METHOXYPHENYL)CYCLOHEXYL]METHYL}-2-{[(4-NITROPHENYL)CARBAMOYL]AMINO}PROPANAMIDE
- CBNumber
- CB33170389
- Molecular Formula
- C32H35N5O5
- Formula Weight
- 569.66
- MOL File
- 1422269-30-4.mol
ML 18 Property
- Boiling point:
- 821.8±65.0 °C(Predicted)
- Density
- 1.291±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: soluble
- form
- A solid
- pka
- 11.99±0.46(Predicted)
- color
- White to yellow
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- 27319
- Product name
- ML-18
- Packaging
- 500μg
- Price
- $35
- Updated
- 2024/03/01
- Product number
- 27319
- Product name
- ML-18
- Packaging
- 1mg
- Price
- $67
- Updated
- 2024/03/01
- Product number
- 27319
- Product name
- ML-18
- Packaging
- 5mg
- Price
- $193
- Updated
- 2024/03/01
- Product number
- 27319
- Product name
- ML-18
- Packaging
- 10mg
- Price
- $315
- Updated
- 2024/03/01
- Product number
- M425185
- Product name
- ML18
- Packaging
- 1mg
- Price
- $90
- Updated
- 2021/12/16
ML 18 Chemical Properties,Usage,Production
Description
ML-18 is a non-peptide bombesin receptor subtype 3 (BB3) antagonist that inhibits [125I]BA1 binding to NCI-H1299 lung cancer cells transfected with human BB3 receptors (IC50 = 4.8 μM). It is selective for BB3 over the gastrin releasing peptide receptor (GRPR) and the neuromedin B receptor (NMBR) with IC50 values of 16 and >100 μM, respectively, in a radioligand binding assay. ML-18 (16 μM) reversibly inhibits BA1-induced increases in cytosolic calcium in NCI-H1299 cells. It also inhibits BA1-induced phosphorylation of ERK and EGFR and reduces proliferation of NCI-H1299 cells.
Uses
ML-18 is a non-peptide bombesin receptor subtype-3 antagonist. It also inhibits lung cancer growth.
ML 18 Preparation Products And Raw materials
Raw materials
Preparation Products
ML 18 Suppliers
- Tel
- --
- Fax
- --
- customerservice@tocris.co.uk
- Country
- United Kingdom
- ProdList
- 5726
- Advantage
- 77